Impaired non-esterified fatty acid suppression to intravenous glucose during late pregnancy persists postpartum in gestational diabetes: a dominant role for decreased insulin secretion rather than insulin resistance
- PMID: 15940468
- DOI: 10.1007/s00125-005-1775-6
Impaired non-esterified fatty acid suppression to intravenous glucose during late pregnancy persists postpartum in gestational diabetes: a dominant role for decreased insulin secretion rather than insulin resistance
Abstract
Aims/hypothesis: Non-esterified fatty acids are implicated in the pathogenesis of gestational (GDM) and type 2 diabetes. We examined the relationship between NEFA dynamics, insulin resistance and beta cell dysfunction in women with GDM in late pregnancy and postpartum.
Methods: A total of 19 Caucasian women with GDM and 19 healthy pregnant women matched for BMI and age underwent an IVGTT in the third trimester and 4 months postpartum, deriving values for insulin sensitivity (SI), insulin secretion (AIRg) and disposition index (DI). NEFA levels were measured serially.
Results: In pregnancy, the GDM women had similar SI but reduced AIRg and DI compared with control subjects. The GDM group demonstrated significantly slower NEFA suppression, which was attributable to the GDM women who required insulin during pregnancy (n=7) and who had markedly reduced AIRg and K(NEFA) (NEFA disappearance constant) compared with their matched controls. In contrast, GDM subjects not requiring insulin (n=12) had similar NEFA suppression curves and AIRg to control subjects. Postpartum, GDM subjects demonstrated reduced SI and DI. The impaired suppression of NEFA persisted postpartum, but again only in the subgroup of GDM subjects who had required insulin during pregnancy. Furthermore, K(NEFA) correlated with AIRg and DI in both states, but not with SI.
Conclusions/interpretation: Impaired NEFA suppression occurs in GDM subjects both in late pregnancy and postpartum in response to IVGTT-induced endogenous insulin secretion. The impaired NEFA suppression is present in GDM women with the most severe beta cell dysfunction (who had required insulin during pregnancy) and is related to their insulin secretory dysfunction rather than their reduced SI.
Similar articles
-
The impact of acute elevation of non-esterified fatty acids on insulin sensitivity and secretion in women with former gestational diabetes.Clin Endocrinol (Oxf). 2005 Jan;62(1):79-84. doi: 10.1111/j.1365-2265.2004.02177.x. Clin Endocrinol (Oxf). 2005. PMID: 15638874
-
Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus.J Clin Endocrinol Metab. 2001 Feb;86(2):568-73. doi: 10.1210/jcem.86.2.7137. J Clin Endocrinol Metab. 2001. PMID: 11158010
-
Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy.Diabetes Metab Res Rev. 2006 Mar-Apr;22(2):131-8. doi: 10.1002/dmrr.591. Diabetes Metab Res Rev. 2006. PMID: 16170833
-
Gestational diabetes mellitus and subsequent development of overt diabetes mellitus.Dan Med Bull. 1998 Nov;45(5):495-509. Dan Med Bull. 1998. PMID: 9850811 Review.
-
Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management.Diabetes. 1991 Dec;40 Suppl 2:18-24. doi: 10.2337/diab.40.2.s18. Diabetes. 1991. PMID: 1748255 Review.
Cited by
-
Advances in free fatty acid profiles in gestational diabetes mellitus.J Transl Med. 2024 Feb 19;22(1):180. doi: 10.1186/s12967-024-04922-4. J Transl Med. 2024. PMID: 38374136 Free PMC article. Review.
-
Association between serum free fatty acids and gestational diabetes mellitus.Front Endocrinol (Lausanne). 2024 Nov 28;15:1451769. doi: 10.3389/fendo.2024.1451769. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39669494 Free PMC article.
-
Insulin resistance as estimated by the homeostatic method at diagnosis of gestational diabetes: estimation of disease severity and therapeutic needs in a population-based study.BMC Endocr Disord. 2013 Jul 2;13:21. doi: 10.1186/1472-6823-13-21. BMC Endocr Disord. 2013. PMID: 23819910 Free PMC article.
-
Coordinated regulation of gene expression and microRNA changes in adipose tissue and circulating extracellular vesicles in response to pioglitazone treatment in humans with type 2 diabetes.Front Endocrinol (Lausanne). 2022 Aug 31;13:955593. doi: 10.3389/fendo.2022.955593. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36120427 Free PMC article. Clinical Trial.
-
Correction of insulin sensitivity and glucose disposal after pancreatic islet transplantation: preliminary results.Diabetes Obes Metab. 2010 Nov;12(11):994-1003. doi: 10.1111/j.1463-1326.2010.01290.x. Diabetes Obes Metab. 2010. PMID: 20880346 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical